Neurology News

Ecopipam, a novel investigational compound for central nervous system disorders significantly reduced symptoms of Tourette syndrome in a cohort of pediatric patients, according to the manufacturer.

A new set of evidence-based guidelines for ALS genetic testing are focused on improving knowledge among all stakeholders, according to a report in the Annals of Clinical and Translational Neurology.

The FDA has granted orphan drug designation to an investigational oral therapeutic for the treatment of Huntington’s disease, according to the manufacturer.

Robert C. Stowe, MD, an instructor of neurology at Boston Children’s Hospital and Harvard Medical School, discusses highlights from the Child Neurology Society annual meeting in this Healio video.

For individuals exposed to athletic-related head contact, glial fibrillary acidic protein may help identify those who are at risk for progressive regional brain atrophy and cognitive decline, per data from Alzheimer’s Research & Therapy.

Treatment with an oral suspension of active gold as an adjunct to disease-modifying therapy was linked to improved neurological function in those with stable relapsing MS, according to a poster presented at ECTRIMS 2023.

For those with relapsing-remitting MS, treatment with diroximel fumarate was linked to better outcomes at 96 weeks compared with those given interferon beta-1a, according to a presentation at ECTRIMS 2023.

A new study links some neurocognitive symptoms of long COVID to persistent SARS-CoV-2 infection in the gut, which triggers a series of reactions that lowers serotonin levels.

In a cohort of individuals with MS, a diagnosis of COVID-19 was linked to an increased risk of disability progression compared with those without, according to a presentation from ECTRIMS 2023.

A novel oncolytic virus gene therapy extended survival among a small cohort of patients with high-grade glioblastoma, according to study results published in Nature.